Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neurons are the fundamental structural and functional units of the brain and nervous system, responsible for receiving sensory input, processing information, and transmitting motor [@axon2011]
commands through sophisticated electrical and chemical signaling mechanisms. These specialized cells form the cellular basis of all nervous system functions, including cognition, [@membrane2009]
memory, emotion, perception, and voluntary movement. The human brain contains approximately 86 billion neurons, each capable of connecting to thousands of other neurons through [@ion2001]
synaptic connections, creating a vast network of over 100 trillion synapses[@pyramidal2008]. [@huntingtons2020]
A typical neuron consists of several distinct compartments, each with specialized functions: [@alzheimers2002]
The cell body, also known as the soma, contains the nucleus and majority of cellular organelles necessary for protein synthesis, energy metabolism, and maintenance of cellular [@alzheimers2010]
homeostasis. The soma typically measures 10-100 micrometers in diameter and serves as the metabolic center of the neuron. Within the soma, the nucleus contains the genetic material [@parkinsons2015]
(DNA) and regulates gene expression, while the cytoplasm houses mitochondria for energy production, the endoplasmic reticulum and Golgi apparatus for protein synthesis and [@amyotrophic2017]
processing, and the cytoskeleton for structural support[@axon2011]. [@huntingtonpathway1993]
Dendrites are branching extensions that emerge from the cell body and form the primary receptive surface of the neuron. These structures are covered with thousands of small [@apoptosis2000]
protrusions called dendritic-spines, which receive synaptic inputs from other neurons. Dendrites integrate incoming signals through both temporal and spatial summation, allowing [@necroptosis2017]
neurons to weigh the relative importance of different inputs. The extensive branching pattern of dendrites can create thousands of synaptic connections, enabling complex [@role2019]
integration of information[@membrane2009]. [@role2013]
The axon is a single, typically long process that transmits electrical signals away from the cell body toward target cells. Axons can range in length from a few millimeters to over [@neurodegenerative]
a meter (as in motor-neurons that extend from the spinal-cord to muscles). The axon is surrounded by a myelin sheath, which is formed by [@genes]
oligodendrocytes in the central nervous system and Schwann cells in the peripheral nervous system. This myelin insulation enables saltatory [@mechanisms]
conduction, dramatically increasing the speed of electrical signal transmission[@ion2001]. [@proteins]
Synapses are specialized junctions where neurons communicate with each other or with effector cells such as muscle fibers. Each neuron typically forms 1,000 to 10,000 synapses, [@ncbi]
allowing for massive parallel information processing. Synaptic transmission can be either electrical (through gap junctions) or chemical (through neurotransmitter release). [@uniprot]
Chemical synapses are the most common type in the vertebrate nervous system and are primary targets of pathological changes in neurodegenerative diseases[@huntingtons2020]. [@ref]
Neurons communicate through electrical signals called action potentials - brief, stereotypic depolarizations that propagate along the axon. Action potentials are generated by the
opening of voltage-gated sodium channels, followed by voltage-gated potassium channels, creating a rapid upstroke and subsequent repolarization. This all-or-none phenomenon allows
for faithful transmission of information over long distances[@alzheimers2002].
At synapses, action potentials trigger the release of neurotransmitters from presynaptic terminals. These chemical messengers diffuse across the synaptic cleft and bind to
receptors on the postsynaptic membrane, either exciting or inhibiting the target neuron. Key neurotransmitters include glutamate (excitatory), GABA (inhibitory), acetylcholine,
dopamine, and serotonin. Dysregulation of synaptic transmission is a hallmark of neurodegenerative diseases[@alzheimers2010].
Neurons in alzheimers exhibit several characteristic pathological changes:
Programmed cell death pathways are activated in many neurodegenerative conditions. The intrinsic (mitochondrial) pathway is triggered by cellular stress signals, leading to
cytochrome c release and caspase-9 activation. The extrinsic pathway involves death receptor activation and caspase-8. While apoptosis is a regulated process, excessive activation
contributes to progressive neuronal loss[@role2019].
A programmed form of necrosis mediated by receptor-interacting protein kinases (RIPK1, RIPK3) and mixed lineage kinase domain-like protein (MLKL). necroptosis is increasingly recognized in Alzheimer's, Parkinson's, and ALS, and may represent a therapeutic target[@role2013].
An iron-dependent form of non-apoptotic cell death characterized by lipid peroxidation. Evidence suggests ferroptosis contributes to neuronal loss in alzheimers and parkinsons. The system Xc-/glutathione/GPX4 axis is the key regulatory pathway[@neurodegenerative].
Neurons rely heavily on autophagymechanisms/autophagy) to clear misfolded proteins and damaged organelles. Impairment of the autophagy-lysosomal pathway and ubiquitin-proteasome-system leads to accumulation of toxic protein aggregates, contributing to neurodegeneration[@genes].
The study of Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Neurons are the fundamental computational units of the nervous system, specializing in electrical and chemical signal transmission. The diversity of neuronal types, their intricate connectivity, and the complexity of synaptic transmission underlie all aspects of brain function. In neurodegenerative diseases, selective neuronal populations undergo progressive dysfunction and death, leading to the characteristic cognitive, motor, and behavioral symptoms of these disorders. Understanding the molecular mechanisms of neuronal vulnerability, including mitochondrial dysfunction, protein aggregation, and excitotoxicity, is essential for developing neuroprotective strategies. Advances in stem cell technologies and neuronal reprogramming offer potential avenues for neuronal replacement therapy in the future.
Neurons are the fundamental computational units of the nervous system, and their dysfunction underlies all neurodegenerative diseases. The selective vulnerability of specific neuronal populations—such as cholinergic neurons in the basal forebrain in Alzheimer's disease, dopaminergic neurons in the substantia nigra in Parkinson's disease, and motor neurons in ALS—reflects intrinsic molecular and structural differences that determine susceptibility to pathological insults. Understanding the mechanisms of neuronal death, including excitotoxicity, oxidative stress, mitochondrial dysfunction, and impaired proteostasis, is essential for developing neuroprotective therapies. Emerging approaches such as gene therapy, stem cell replacement, and targeted small molecules aim to preserve or replace vulnerable neurons, offering hope for disease modification in neurodegenerative disorders.